Table 3 Immunophenotype of 7 patients with AML-M2/M3 by FCM
No. | CD45(blast) | CD9 | CD13 | CD33 | CD34 | cMPO | CD117 | HLA-DR | CD11b | CD15 | CD38 | CD56 | D64 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case 1 | 81.1 | 47.5 | 32.7 | 46.9 | ā | ā | ā | ā | ā | ā | 41.0 | ā | ā | |
Case 2 | 69.0 | ā | 47.0 | 62.9 | 78.1 | ā | 55.1 | 85.4 | ā | ā | ā | ā | ā | |
Case 3 | 80.3 | 93.2 | 87.2 | 97.3 | 16.2 | 96.4 | ā | ā | ā | ā | ā | ā | ā | |
Case 4 | 83.7 | 92.5 | ā | 97.0 | ā | 98.9 | 16.4 | ā | 12.7 | ā | ā | ā | 86.7 | |
Case 5 | 76.4 | ā | 30.9 | 95.5 | ā | 78.4 | 78.4 | ā | ā | 11.6 | ā | 96.5 | 16.9 | |
Case 6 | 44.9 | CD34/HLA-DR 29.6%, CD15 6.5%, CD14/CD11b 0.2%, HLA-DR/CD13 3.5% | ||||||||||||
Case 7 | 84.5 | 36.2 | ā | 90.8 | 82.6 | 62.3 | 97.8 | 88.0 | 85.9 | 13.5 | 40.3 | ā | 12.4 | 7.9 |
48.3 | ā | 94.9 | 83.0 | ā | 98.9 | 43.8 | 35.0 | 46.6 | 95.3 | ā | 26.1 | 70.4 | ||